Search Results

There are 24034 results for: content related to: Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of disease

  1. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation

    Journal of Cellular Physiology

    Volume 208, Issue 1, July 2006, Pages: 220–228, Tiziana Servidei, Anna Riccardi, Maurizio Sanguinetti, Carlo Dominici and Riccardo Riccardi

    Article first published online : 30 MAR 2006, DOI: 10.1002/jcp.20659

  2. You have free access to this content
    In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells

    Cancer

    Volume 94, Issue 10, 15 May 2002, Pages: 2653–2662, Barbara Scappini, Francesco Onida, Hagop M. Kantarjian, Li Dong, Srdan Verstovsek, Michael J. Keating and Miloslav Beran

    Article first published online : 14 MAY 2002, DOI: 10.1002/cncr.10543

  3. You have free access to this content
    Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein

    Cancer

    Volume 100, Issue 7, 1 April 2004, Pages: 1459–1471, Barbara Scappini, Simona Gatto, Francesco Onida, Clara Ricci, Vladimir Divoky, William G. Wierda, Michael Andreeff, Li Dong, Kimberly Hayes, Srdan Verstovsek, Hagop M. Kantarjian and Miloslav Beran

    Article first published online : 25 FEB 2004, DOI: 10.1002/cncr.20131

  4. You have free access to this content
    Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma

    Cancer

    Volume 103, Issue 9, 1 May 2005, Pages: 1800–1809, Ryungsa Kim, Manabu Emi, Koji Arihiro, Kazuaki Tanabe, Yoko Uchida and Tetsuya Toge

    Article first published online : 22 MAR 2005, DOI: 10.1002/cncr.20973

  5. You have free access to this content
    Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement

    International Journal of Cancer

    Volume 92, Issue 3, 1 May 2001, Pages: 354–360, A. Greco, E. Roccato, C. Miranda, L. Cleris, F. Formelli and M.A. Pierotti

    Article first published online : 28 FEB 2001, DOI: 10.1002/ijc.1190

  6. You have free access to this content
    Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents

    British Journal of Haematology

    Volume 123, Issue 5, December 2003, Pages: 858–868, Atanasio Pandiella, Xonia Carvajal-Vergara, Soraya Tabera, Gema Mateo, Norma Gutiérrez and Jesús F. San Miguel

    Article first published online : 19 NOV 2003, DOI: 10.1046/j.1365-2141.2003.04706.x

  7. The effects of STI571 on antigen presentation of dendritic cells generated from patients with chronic myelogenous leukemia

    Hematological Oncology

    Volume 21, Issue 2, June 2003, Pages: 67–75, Naoko Sato, Miwako Narita, Masuhiro Takahashi, Kumiko Yagisawa, Aichun Liu, Takashi Abe, Kohji Nikkuni, Tatsuo Furukawa, Ken Toba and Yoshifusa Aizawa

    Article first published online : 20 JAN 2003, DOI: 10.1002/hon.705

  8. You have full text access to this Open Access content
    Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells

    Cancer Science

    Volume 94, Issue 6, June 2003, Pages: 557–563, Motoi Mukai, Xiao-Fang Che, Tatsuhiko Furukawa, Tomoyuki Sumizawa, Shunji Aoki, Xiao-Qin Ren, Misako Haraguchi, Yoshikazu Sugimoto, Motomasa Kobayashi, Hideo Takamatsu and Shin-ichi Akiyama

    Article first published online : 19 AUG 2005, DOI: 10.1111/j.1349-7006.2003.tb01482.x

  9. You have free access to this content
    In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy

    International Journal of Cancer

    Volume 113, Issue 5, 20 February 2005, Pages: 849–856, Didier Decaudin, Patricia de Cremoux, Xavier Sastre, Jean-Gabriel Judde, Fariba Nemati, Carine Tran-Perennou, Paul Fréneaux, Alain Livartowski, Pierre Pouillart and Marie-France Poupon

    Article first published online : 21 OCT 2004, DOI: 10.1002/ijc.20652

  10. You have free access to this content
    Sti571-induced Stevens–Johnson Syndrome

    British Journal of Haematology

    Volume 119, Issue 1, October 2002, Pages: 274–275, D. Vidal , L. Puig , A. Sureda  and A. Alomar 

    Article first published online : 2 OCT 2002, DOI: 10.1046/j.1365-2141.2002.37133.x

  11. Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patients

    Histopathology

    Volume 46, Issue 5, May 2005, Pages: 540–550, J Thiele, H M Kvasnicka, A Schmitt-Graeff, S Kriener, K Engels, P Staib, E S Ollig, C Keller, S Fokkema, M Griesshammer, C F Waller, O G Ottmann and M L Hansmann

    Article first published online : 17 MAR 2005, DOI: 10.1111/j.1365-2559.2005.02119.x

  12. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells

    Journal of Cellular Physiology

    Volume 198, Issue 3, March 2004, Pages: 370–376, Kanoko Kohmura, Yoshitaka Miyakawa, Yoko Kawai, Yasuo Ikeda and Masahiro Kizaki

    Article first published online : 23 SEP 2003, DOI: 10.1002/jcp.10426

  13. You have free access to this content
    Mutation in the ATP-binding site of BCR-ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571

    British Journal of Haematology

    Volume 119, Issue 1, October 2002, Pages: 109–111, Christophe Barthe, Marie-josée Gharbi, Valérie Lagarde, Claudine Chollet, Pascale Cony-Makhoul, Josy Reiffers, John M. Goldman, Junia V. Melo and François Xavier Mahon

    Article first published online : 2 OCT 2002, DOI: 10.1046/j.1365-2141.2002.03708.x

  14. You have free access to this content
    Position paper on imatinib mesylate in chronic myeloid leukaemia

    British Journal of Haematology

    Volume 119, Issue 1, October 2002, Pages: 268–272, Stephen G. O'Brien and Simon A. J. Rule

    Article first published online : 2 OCT 2002, DOI: 10.1046/j.1365-2141.2002.39201.x

  15. You have free access to this content
    Effects of combinations of therapeutic agents on the proliferation of progenitor cells in chronic myeloid leukaemia

    British Journal of Haematology

    Volume 116, Issue 1, January 2002, Pages: 162–165, Stephen B. Marley, R. John Davidson, John M. Goldman and Myrtle Y. Gordon

    Article first published online : 3 OCT 2008, DOI: 10.1046/j.1365-2141.2002.03237.x

  16. Tyrosine kinase inhibitors: From rational design to clinical trials

    Medicinal Research Reviews

    Volume 21, Issue 6, November 2001, Pages: 499–512, Peter Traxler, Guido Bold, Elisabeth Buchdunger, Giorgio Caravatti, Pascal Furet, Paul Manley, Terence O'Reilly, Jeanette Wood and Juerg Zimmermann

    Article first published online : 5 OCT 2001, DOI: 10.1002/med.1022

  17. You have free access to this content
    Combination therapy with imatinib mesylate (sti571): synopsis of in vitro studies

    British Journal of Haematology

    Volume 119, Issue 1, October 2002, Pages: 3–14, J. Topaly, W. J. Zeller and S. Fruehauf

    Article first published online : 2 OCT 2002, DOI: 10.1046/j.1365-2141.2002.03806.x

  18. Influence of the tyrosine kinase inhibitors STI571 (Glivec®), lavendustin A and genistein on human mast cell line (HMC-1560) activation

    Journal of Cellular Biochemistry

    Volume 103, Issue 4, 1 March 2008, Pages: 1076–1088, Kristin Löber, Amparo Alfonso, Luis Escribano and Luis M. Botana

    Article first published online : 27 JUL 2007, DOI: 10.1002/jcb.21480

  19. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors

    Journal of Cellular Physiology

    Volume 218, Issue 3, March 2009, Pages: 568–574, Huei-Mei Huang and Juo-Chuan Liu

    Article first published online : 12 NOV 2008, DOI: 10.1002/jcp.21627

  20. STI571 (Glivec®) affects histamine release and intracellular pH after alkalinisation in HMC-1560, 816

    Journal of Cellular Biochemistry

    Volume 103, Issue 3, 15 February 2008, Pages: 865–876, Kristin Löber, Amparo Alfonso, Luis Escribano and Luis M. Botana

    Article first published online : 5 JUL 2007, DOI: 10.1002/jcb.21458